Deborah Taylor Tate is Director at HEALTHSTREAM INC (HSTM). They have made 9 open-market trades across 1 company since 2013, most recently 2026-06-08.
CIK 0001500801
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 9 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| HSTM | 24,699 | $802K |
Shares reported on the most recent Form 4, priced at the 2026-06-09 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| HSTM | SELL | 2025-11-26 | 2025-12-01 | $25.46 | $40K | -4.0% | -9.0% | -15.7% |
| HSTM | SELL | 2024-08-29 | 2024-08-29 | $28.53 | $40K | -3.0% | +0.2% | +14.8% |
| HSTM | SELL | 2023-02-24 | 2023-02-24 | $25.26 | $170K | +1.1% | +6.1% | -6.4% |
| HSTM | SELL | 2021-08-16 | 2021-08-16 | $30.35 | $30K | -5.2% | -7.7% | -14.7% |
| HSTM | SELL | 2019-10-31 | 2019-11-01 | $28.29 | $367K | -2.7% | +1.4% | -9.2% |
| HSTM | SELL | 2018-03-07 | 2018-03-07 | $24.32 | $292K | +0.4% | -0.5% | +14.7% |
| HSTM | SELL | 2016-08-15 | 2016-08-15 | $24.28 | $73K | +7.2% | +7.1% | +5.3% |
| HSTM | SELL | 2014-08-13 | 2014-08-14 | $26.05 | $52K | -10.0% | -1.2% | -1.2% |
| HSTM | SELL | 2013-03-11 | 2013-03-12 | $20.86 | $81K | -10.0% | -1.2% | -1.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.